New YorkNew York(NY) Rheingold, David B. personal infomation and areas of practice

New York New YorkRheingold, Valet, Rheingold, McCartney & Giuffra LLP attorney Rheingold, David B. is a Very good lawyer practice area in Active Trial Practice Drug Product Medical Device Liability Cases Mass Tort Cases Personal Injury Cases 100% of Practice Devoted to Litigation ,Drugs & Medical Devices, Health Care, Litigation & Appeals, Personal Injury, Products Liability, Science & Technology, Toxic Torts,Rheingold, Valet, Rheingold, McCartney & Giuffra LLP

if you have any problem in Tort Cases Personal Injury Cases 100% of Practice Devoted to Litigation ,Drugs & Medical Devices, Health Care, Litigation & Appeals, Personal Injury, Products Liability, Science & Technology, Toxic Torts,please email to Rheingold, Valet, Rheingold, McCartney & Giuffra LLP or call 888-335-9457 or Go to our company directly(addr:113 East 37th Street New York,NY) ,we will provide free legal advice for you.

• David B. Rheingold specializes in an active trial practice primarily involving drug product and medical device liability cases. Since joining our firm in 1993, he has concentrated on the mass tort cases, most recently hip and knee implant litigation in both federal and state courts. This includes the following implants: Biomet M2a, DePuy ASR & Pinnacle, Stryker, Wright Medical, and Zimmer. For knee implants, he litigates in federal court for the Zimmer NexGen knee implant. He litigates hernia and pelvic mesh cases in state and federal courts against the following defendants: AMS, Bard, Boston Scientific, Coloplast, Ethicon, and Gynemesh. Drug litigation is also a large part of his federal and state practice and includes: Benicar, Yaz/Yasmin/Beyaz, NuvaRing, Fosamax, Actonel, Boniva, Heparin, Levaquin, and Reglan. His direct involvement in management of specific litigations includes courts in New York, New Jersey, and federal courts throughout the United States.

  He is the managing partner for the firm’s cases in the $2.5 billion DePuy ASR metal-on-metal hip implant settlement plan; $100 million NuvaRing settlement program; the $56 million Biomet Magnum and 38 M2a hip implants; and the $27.7 million settlement program for the firm's Fosamax osteonecrosis of the jaw cases. He has used his medical expertise in preparing the firm's "Extraordinary Injury" and "Enhanced Injury" claims for recent medical device litigations: Medtronic Defibrillator, Guidant Defibrillator, Medtronic Sprint Fidelis Lead litigations, DePuy ASR and Biomet hip implants. The Rheingold firm had leadership positions in Medtronic and Guidant litigations which settled for $118 million, $195 million and $268 million respectively.

  As an active member in the American Association for Justice, City Bar Association of New York, and the New York State Trial Lawyers, he has access to litigation resources and materials throughout the United States. His is the co-chair for the Fosamax and Other Bisphosphonates Litigation Group. This local and national experience makes him a valuable lecturer to other trial attorneys on handling mass tort cases, and he provides annual lectures to New York State Trial Lawyers at the annual "Decisions" seminars throughout New York State. He has been a guest lecturer at law schools and the Attorneys Exchange Information Group.

  He has management responsibilities at the firm, including our firm's public service news reporting on these firm website areas: Medical Malpractice Blog, Negligence Blog, Articles, "Greed & Misdeeds" section, and Spanish content. He believes strongly in exposing college and law students to the practice of law, so he manages our year round internship program.

  On both a local and national level, he has obtained substantial client settlements through arbitration, mediation and direct negotiations with some of the largest national and international drug and medical device makers. Prior to joining the firm, David practiced in Virginia handling personal injury cases. David can be e-mailed directly at drheingold@rheingoldlaw.com.

• New York, 1994 New Jersey Virginia, 1988 U.S. District Court Southern District of New York, 1994 U.S. District Court Eastern District of New York, 1994

• American Association for Justice (Member) City Bar Association of New York (Member) New York State Trial Lawyers (Member)

• University of Richmond, The T.C. Williams School of Law, Richmond, Virginia, 1988J.D. Oberlin College, Oberlin, Ohio, 1984B.A.Major: Sociology

• At Rheingold, Valet, Rheingold, McCartney & Giuffra LLP, our attorneys are active members and leaders of a number of legal committees and associations, including the American Association for Justice and the Board of Directors of the New York State Trial Lawyers. Paul Rheingold, Thomas Valet, and David Rheingold were voted 2010 Super Lawyers.

  Our founder, Paul Rheingold, has been practicing law since 1958. Throughout his years of practice, he has been active in complex litigation, including leadership and educational roles in over 20 drug and medical device mass tort claims.

  Our experience in areas such as auto product liability and defective medical products has earned us an accomplished reputation in the legal community. We feel this often gives us unique experience in negotiating settlements with insurance companies and other defendants on behalf of our clients. Our experience has been instrumental in us establishing a proven record of jury awards and settlements for our clients.

  ?

  *Please note we are no longer taking Levaquin, Actonel, Boniva, or Fosomax cases; or those related to ONJ (ostenecrosis of the jaw).

  ?

Rheingold, Valet, Rheingold, McCartney & Giuffra LLP & Joy Attorneys

New York New York lawyer Giuffra, Thomas P. New York New York lawyer Kagan, Scott Daniel New York New York lawyer Hellman, Jeremy New York New York lawyer McCartney, Terrence E. New York New York lawyer Plotkin, Sherri L. New York New York lawyer Rheingold, David B. New York New York lawyer Rheingold, Paul D. New York New York lawyer Valet, Thomas P.

Active Trial Practice Drug Product Medical Device Liability Cases Mass Tort Cases Personal Injury Cases 100% of Practice Devoted to Litigation ,Drugs & Medical Devices, Health Care, Litigation & Appeals, Personal Injury, Products Liability, Science & Technology, Toxic Torts legal template form download

lawyer Rheingold, David B. Reviews

Litigation

Health care

Litigation

First, how defunct is the company? By that I mean does somebody still have rights to the company name? Would they be willing to file suit to protect their brand name?. . Second, do you want to associate the name of your company to one that has already failed?. . Third, how often will you have to reassure new business prospects that " No, we are not the same company as the now failed Pandemic Studios". . If it were me I wouldn't do it, legal or not.

What is formal and informal letter writing format for cbse 11std. Please i need it fast?

Probability = (Number of ways of forming 4-letter code based on the requirement) / (Number of ways of forming any 4-letter code). = [ (13 C 3) . (4 C 1) . 4! ] / [ (17 C 4) . 4! ]. . In the numerator, we:. - choose 3 non-vowels out of 13 such. - choose 1 vowel out of 4 such. - permutate the 4 letters. then we use the multiplication principle, since these events are sequential.. . In the denominator, we:. - choose any 4 letters out of 17. - permutate the 4 letters. then we use the multiplication principle for the same reason as above.. . Hope you could undestand. Keep at it!

It uses multiple tables to organize information

You need to write a letter and a CV in exactly the same way as you would if you were applying for a job.. . That means you research the correct person to send the letter to

Form 6781 is only used if you had Section 1256 contracts or what the IRS calls a straddle.. . For a privite investor, the only Section 1256 contracts you are likely to have traded would be cash settled options on a broad based index, such as SPX or OEX options.. . The IRS defines a straddle as "any set of offsetting positions on personal property." That includes not only what option traders define as straddles, but most other spreads as well, including vertical spreads and time spreads. The only offsetting positions including at least one option position that the IRS does not consider a straddle is a "qualified covered call." If you had any covered calls see page 59 or IRS publication 550 to determine if the covered call was qualified or not.. . If an option trade was not a Section 1256 contract and was not part of a straddle, report it on Schedule D (for the year the trades was closed) unless the postion was closed through the exercise or assignment process. If you exercised a long option position or were assigned a short option position, adjust the price of the underlying by the amount of the option premium instead of reporting the option trade separately.

this is the lawyers reviews